拜瑞妥用于预防房颤产生的卒中需要使用多久？拜瑞妥房颤剂量多少？

Xarelto (rivaroxaban), produced by Bayer HealthCare, is indicated for the prevention of venous thrombosis (VTE) in adult patients undergoing elective hip or knee replacement surgery. (rivaroxaban) is indicated for use in adult patients with non-valvular atrial fibrillation who have one or more risk factors (e.g., congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, history of stroke or transient ischemic attack) to reduce the risk of stroke and systemic embolism. It can selectively and directly inhibit bound or free factor Next, let us understand the usage and dosage of this drug.

How long should Xarelto be used to prevent stroke caused by atrial fibrillation? What is the dose of Xarelto for atrial fibrillation? Rivaroxaban is used in adult patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism: the recommended dose of Rivaroxaban is 20 mg once a day, which is also the maximum recommended dose. For patients with low weight and advanced age (>75 years old), doctors can use 15 mg once a day as appropriate based on the patient's condition. Since each patient's disease stage and personal constitution are different, the length of time Xarelto needs to be used to prevent stroke caused by atrial fibrillation is also different, which is determined by the patient's disease stage and personal constitution.

Eisenberg MJ et al. meta-analyzed five randomized controlled studies (a total of 23,063 patients were included in the study, all of whom took Rivaroxaban for ≥1 month, including 14,264 cases of non-valvular atrial fibrillation, 3967 cases of deep vein thrombosis, and 3967 cases of acute symptomatic pulmonary embolism). Example), it was found that compared with vitamin K antagonists, Rivaroxaban did not increase the composite endpoint of major bleeding and clinically relevant bleeding, and fatal bleeding events were significantly reduced in the Rivaroxaban group.

The above is an introduction to Rivaroxaban. If patients have other questions about the drug (such as drug prices, purchase channels, etc.), they can consult the medical companion travel service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: